Safety of Quadrivalent Human Papillomavirus Vaccine (Gardasil®) in Pregnancy: Review of Non-manufacturer reports in the Vaccine Adverse Event Reporting System, 2006 – 2013

BACKGROUND: In 2006, quadrivalent human papillomavirus (HPV4; Gardasil, Merck & Co. Inc.) vaccine was licensed in the US for use in females aged 9 to 26 years. HPV4 is not recommended during pregnancy; however, inadvertent administration during pregnancy may occur. OBJECTIVES: To evaluate and su...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine
Hauptverfasser: Moro, Pedro L., Zheteyeva, Yenlik, Lewis, Paige, Shi, Jing, Yue, Xin, Museru, Oidda I., Broder, Karen
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2014
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6524774/
https://ncbi.nlm.nih.gov/pubmed/25500173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2014.11.047
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge